Dopamine-like activities of an aminopyridazine derivative, CM 30366: A behavioural study
- 1 November 1986
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 334 (3) , 246-252
- https://doi.org/10.1007/bf00508778
Abstract
The behavioural effects of CM 30366, an aminopyridazine derivative, on dopamine-mediated neurotransmissions, have been studied in mice and rats. CM 30366 induced stereotyped behaviour and antagonized haloperidol-induced catalepsy in rats, after parenteral and oral administration. In 6-hydroxy dopamine (6-OHDA)-lesioned mice, CM 30366 induced contralateral rotations and, when injected before 6-OHDA, protected mice against its neurotoxicity. CM 30366 also provoked contralateral rotations when injected directly into the mouse right striatum. After parenteral injection, CM 30366 slightly increased motility in mice, at least at low doses. The stereotypies and rotations (after intrastriatal injection) induced by CM 30366 were antagonized by haloperidol, alphamethyl-p-tyrosine and reserpine. The effects of CM 30366 were compared to those of direct and indirect dopamine-like drugs. Bromocriptine induced a behavioural profile, which in most aspects, was qualitatively and quantitatively similar to that of CM 30366. Apomorphine was found slightly more potent than CM 30366, but in contrast to the latter, apomorphine-induced stereotypies were insensitive to alpha-methyl-p-tyrosine or reserpine. (+)-Amphetamine and nomifensine were less potent than CM 30366, and unlike CM 30366, induced ipsilateral rotations in 6-OHDA-lesioned mice. These results indicate that CM 30366 is a potent atypical dopamine-like drug of potential therapeutic usefulness.This publication has 38 references indexed in Scilit:
- Adverse Effects of Antiparkinsonian DrugsDrugs, 1981
- Predictability and specificity of behavioral screening tests for nucleolepticsPharmacology & Therapeutics, 1979
- NomifensineDrugs, 1979
- Pharmacology of Bromocriptine in Health and DiseaseDrugs, 1979
- Circling induced by dopamine uptake inhibitorsJournal of Pharmacy and Pharmacology, 1978
- LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINEThe Lancet, 1978
- Biochemical and pharmacological studies on amineptine (S 1694) and (+)-amphetamine in the ratJournal of Pharmacy and Pharmacology, 1977
- SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASEThe Lancet, 1977
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: Effects of apomorphine, l-DOPA, amantadine, amphetamine and other psychomotor stimulantsNeuropharmacology, 1973